Federal Supply Schedule 36F79725D032E

Award Date 8/18/25
Last Date to Order 2/14/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The prime contractor is Usantibiotics LLC, a for-profit organization. The contract is an interim agreement with a ceiling value of $25,000.00 and a period of performance through April 1, 2023. The contract does...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The prime contractor is Quallent Pharmaceuticals Health, LLC, a foreign-owned for-profit manufacturer of goods. The contract has a ceiling value of $25,000.00 and a period of performance through...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency. The contract, awarded to Enzyvant Therapeutics Inc., has a ceiling value of $2,100,100.00 and a period of performance ending on July 31, 2023. The purpose of the contract is to provide drugs, pharmaceuticals, and hematology-related products under the 65 I B Federal Supply Class. The contract is a multiple-award vehicle, meaning it can...
The federal contract IDV award is a Federal Supply Schedule contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued at a ceiling of $500,000.00, is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The prime contractor for this multiple-award contract is Usantibiotics LLC, a for-profit organization located in Alpharetta, Georgia. The contract has a period of...
This federal contract IDV is a Federal Supply Schedule (FSS) award under Schedule 65 I B for Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs, to Meitheal Pharmaceuticals, Inc., a for-profit foreign-owned manufacturer. The contract has a ceiling value of $25,000.00 and a period of performance from the award date of December 2, 2024 through May...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Intrabio Inc., a small business joint venture. The contract has a ceiling value of $225,000.00 and a period of performance from July 1, 2025 to June 30, 2030. The contract is for the provision of Drugs, Pharmaceuticals, & Hematology Related Products under FSS contract code 65 I B. While no specific task orders or price lists were...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Invivyd, Inc. The contract has a ceiling value of $225,000.00 and a period of performance from November 15, 2024 to November 14, 2029. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under the FSS contract category 65 I B. The scope of the contract includes the delivery of these medical...
The federal contract IDV is a Federal Supply Schedule awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs. The $340,000,000 contract was awarded to EMD Serono Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods, for a period of performance from January 1, 2025 to December 31, 2029. The contract is for the provision of drugs, pharmaceuticals, and hematology-related products under the FSS 65 I B...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The prime contractor is Reata Pharmaceuticals, Inc., a for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance ending on October 23, 2023. It is a multiple...
  • 36F79725D032E
    Federal Supply Schedule
  • -
    Blanket Purchase Agreements

The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency. The prime contractor is Mesoblast, Inc., a for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance ending on February 14, 2026. The contract aims to procure pharmaceutical and hematology-related products, though the specific products and services to be delivered are not detailed in the provided information. The contract is a multiple award, with no set-aside used.

The summary of the key products and services, task orders, and price lists cannot be provided as the details are not sufficiently covered in the information given. The original solicitation was also not provided, preventing any additional context about the scope and purpose of the contracted products and services.

Generated 8/13/25, 10:42 AM